Journal of ethnopharmacology · 2025
An anticomplement homogeneous polysaccharide from the leaves of Rhododendron dauricum alleviates H1N1-induced pneumonia by reducing neutrophil extracellular trap formation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Jie, Zhao Zhizhi, Wang Donghan, Zhou Lishuang, Chen Daofeng, Lu Yan
Аннотация
ETHNOPHARMACOLOGICAL RELEVANCE: Rhododendron dauricum L. leaves (RDL) are used in traditional Chinese medicine as a heat-clearing herb for pulmonary diseases. Our previous research suggested its anticomplement polysaccharides might help alleviate pneumonia, but their in vivo effects remain unreported.
AIM OF THE STUDY: To obtain a homogeneous polysaccharide from RDL and investigate its anti-pneumonia effects and mechanisms.
MATERIALS AND METHODS: DEAE-52 cellulose and gel permeation chromatography, methylation, and NMR analysis were used to isolate and characterize the homogeneous polysaccharide. Its in vitro anticomplement activity was determined by a hemolytic test. The therapeutic effect and mechanisms on pneumonia were evaluated in H1N1-infected mice. ELISA, immunohistochemistry, immunofluorescence, and Western blot were used to assess inflammatory markers, complement components, neutrophil recruitment, NET formation, and alveolar fluid clearance. Additionally, an H1N1-MRSA co-infection model was established to assess the efficacy of RDLP against dual infections.
RESULTS: RDLP, a homogeneous branched acidic heteropolysaccharide (385.4 kDa), was isolated from RDL. It was mainly composed of arabinose, galactose and rhamnose, and showed significant anticomplement activity in vitro (CH50 = 24.99 ± 1.98 μg/mL). In vivo, RDLP alleviated H1N1-induced pneumonia by reducing lung injury, lung index, weight loss, and inflammatory marker levels. Mechanistically, it inhibited complement over-activation, suppressed neutrophil infiltration and NET formation, and promoted alveolar fluid clearance. RDLP also alleviated pneumonia in H1N1-MRSA co-infection.
CONCLUSION: RDLP alleviated H1N1-induced pneumonia by inhibiting complement activation and reducing NET formation, highlighting its potential as a candidate for pneumonia treatment.
AIM OF THE STUDY: To obtain a homogeneous polysaccharide from RDL and investigate its anti-pneumonia effects and mechanisms.
MATERIALS AND METHODS: DEAE-52 cellulose and gel permeation chromatography, methylation, and NMR analysis were used to isolate and characterize the homogeneous polysaccharide. Its in vitro anticomplement activity was determined by a hemolytic test. The therapeutic effect and mechanisms on pneumonia were evaluated in H1N1-infected mice. ELISA, immunohistochemistry, immunofluorescence, and Western blot were used to assess inflammatory markers, complement components, neutrophil recruitment, NET formation, and alveolar fluid clearance. Additionally, an H1N1-MRSA co-infection model was established to assess the efficacy of RDLP against dual infections.
RESULTS: RDLP, a homogeneous branched acidic heteropolysaccharide (385.4 kDa), was isolated from RDL. It was mainly composed of arabinose, galactose and rhamnose, and showed significant anticomplement activity in vitro (CH50 = 24.99 ± 1.98 μg/mL). In vivo, RDLP alleviated H1N1-induced pneumonia by reducing lung injury, lung index, weight loss, and inflammatory marker levels. Mechanistically, it inhibited complement over-activation, suppressed neutrophil infiltration and NET formation, and promoted alveolar fluid clearance. RDLP also alleviated pneumonia in H1N1-MRSA co-infection.
CONCLUSION: RDLP alleviated H1N1-induced pneumonia by inhibiting complement activation and reducing NET formation, highlighting its potential as a candidate for pneumonia treatment.